Results 201 to 210 of about 94,250 (267)
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors. [PDF]
Yap TA +12 more
europepmc +1 more source
A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors. [PDF]
Siu LL +8 more
europepmc +1 more source
Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations. [PDF]
Methodology for the Development of Innovative Cancer Therapies Taskforce. Electronic address: lseymour@ctg.queensu.ca.
europepmc +1 more source
Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity. [PDF]
Torrado C +24 more
europepmc +1 more source
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit. [PDF]
Braganca Xavier C +18 more
europepmc +1 more source
Los extranjeros no católicos y su relación con los terremotos en Chile durante siglo XIX.
Alfredo Palacios Roa
openalex +1 more source

